Liliane Fossati-Jimack Selected Research

Complement Membrane Attack Complex (Membrane Attack Complex)

1/2021

C3 Drives Inflammatory Skin Carcinogenesis Independently of C5.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liliane Fossati-Jimack Research Topics

Disease

9	Glomerulonephritis 04/2016 - 10/2002
5	Inflammation (Inflammations) 01/2021 - 12/2002
4	Nephritis 08/2012 - 12/2002
3	Rheumatoid Arthritis 01/2022 - 12/2018
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2013 - 06/2003
2	Lupus Nephritis 08/2008 - 03/2006
2	Genetic Predisposition to Disease (Genetic Predisposition) 02/2008 - 02/2007
2	Anemia 06/2007 - 08/2005
1	Neoplasms (Cancer) 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Carcinogenesis 01/2021
1	Hyperplasia 01/2021
1	Necrosis 12/2020
1	Experimental Arthritis 12/2019
1	Tertiary Lymphoid Structures 12/2019
1	Infections 01/2019
1	Arthritis (Polyarthritis) 12/2018
1	Hypertriglyceridemia 09/2015
1	Dyslipidemias (Dyslipidemia) 09/2015
1	Hereditary Complement Deficiency Diseases 01/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2014
1	Hyperlipidemias (Hyperlipidemia) 08/2012
1	Atherosclerosis 08/2012
1	Disease Susceptibility (Diathesis) 01/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2012
1	Cryoglobulinemia 11/2005
1	Autoimmune Diseases (Autoimmune Disease) 12/2004
1	Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis) 10/2002
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 02/2002

Drug/Important Bio-Agent (IBA)

8	Immunoglobulin G (IgG)IBA 01/2021 - 10/2002
8	AutoantibodiesIBA 12/2018 - 02/2002
4	Antigen-Antibody Complex (Immune Complex)IBA 08/2012 - 04/2004
3	Complement System Proteins (Complement)IBA 01/2021 - 11/2005
2	AntibodiesIBA 12/2018 - 02/2008
2	Immunoglobulin M (IgM)IBA 02/2008 - 06/2007
2	CryoglobulinsIBA 11/2005 - 10/2002
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Adalimumab (Humira)FDA Link 01/2021
1	Biological ProductsIBA 01/2021
1	CarcinogensIBA 01/2021
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2021
1	anthraceneIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 12/2020
1	CytokinesIBA 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	interleukin-21 (interleukin 21)IBA 12/2020
1	Protein-Arginine DeiminasesIBA 12/2019
1	Granzymes (Granzyme)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	AntigensIBA 12/2018
1	Interleukin-27 (Interleukin 27)IBA 12/2018
1	Complement C3b (C3bi)IBA 04/2016
1	Triglycerides (Triacylglycerol)IBA 09/2015
1	Lipoproteins (Lipoprotein)IBA 09/2015
1	Pertussis ToxinIBA 09/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Interleukin-33IBA 05/2014
1	Histidine (L-Histidine)FDA Link 01/2013
1	Arginine (L-Arginine)FDA Link 01/2013
1	Fas Ligand Protein (Fas Ligand)IBA 01/2012
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 08/2008
1	Glycoproteins (Glycoprotein)IBA 08/2008
1	Complement Receptors (Complement Receptor)IBA 06/2007
1	Immunoglobulin A (IgA)IBA 06/2007
1	Fc Receptors (Fc Receptor)IBA 06/2007
1	ElementsIBA 02/2007
1	Indicators and Reagents (Reagents)IBA 03/2006
1	DNA (Deoxyribonucleic Acid)IBA 04/2004
1	LigandsIBA 06/2003
1	Rheumatoid FactorIBA 10/2002
1	EpitopesIBA 02/2002

Therapy/Procedure

2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2012 - 12/2004
1	Biological Therapy 01/2022
1	Therapeutics 01/2021